Novo Nordisk has revealed that the heart protective benefits of its obesity treatment, Wegovy, are not solely due to weight loss. New data presented at a medical meeting suggests that…
Novo Nordisk has revealed that the heart protective benefits of its obesity treatment, Wegovy, are not solely due to weight loss. New data presented at a medical meeting suggests that…
By News Team November 11, 2023